Vaccine Assays | Clinical Research Company in India

Immunogenicity Assessment (Humoral & Cellular)

We support comprehensive immune response characterization, including

Binding antibody assays (e.g., antigen specific IgG/IgM/IgA)

Neutralizing antibody assays (live virus, or surrogate formats, as appropriate)

Avidity and functional antibody assessments (where relevant to mechanism)

Cell-mediated immunity evaluations (e.g., T cell response profiling)

Cytokine and immune marker profiling to support immune monitoring and correlates exploration

Plaque Reduction Neutralization Test (PRNT)

Vaccine assays often evolve as clinical understanding advances. Cliantha Vaccines offers

Assay development and optimization (sensitivity, specificity, selectivity, robustness)
Fit for purpose qualification for exploratory and early phase use
Method validation/verification aligned to intended use and applicable guidelines
Matrix and interference assessments to support real world sample performance
Protocol-driven execution with controlled documentation and traceability

Quality is built into every stage of our workflow—from method design to reporting. Our teams operate using

Depending on your program needs, we provide sponsor-ready outputs such as:

Validated/qualified assay reports and method documentation
Sample analysis results with clear QC summaries
Data tables and interpretive summaries aligned to study endpoints
Technical transfer/bridging documentation when required
Deviation and investigation documentation (where applicable) with impact assessment

Sponsors choose Cliantha Vaccines for:

Large Molecule